Results of Individualized Intervention in Gestational Diabetes

M. Gyves,P. Schulman,I. Merkatz
DOI: https://doi.org/10.2337/diacare.3.3.495
1980-05-01
Diabetes Care
Abstract:Intervention for the gestational diabetic woman at MacDonald House, University Hospitals of Cleveland, consists primarily of dietary management. Caloric intake is not restricted, since every attempt is made to meet the protein-calorie recommendations for a normal pregnancy. Most women are placed on a 2200-2400-cal diet, although, because many of the gestational diabetic women are obese, caloric intakes of more than 3000 cal are not uncommon. Carbohydrates make up 45% or more of the total calories, and monosaccharides are avoided, except for those in natural sources. Twenty percent of the diet is made up of protein, usually totaling 115 g. Adequate weight gain and the maintenance of euglycemia are the goals of the dietary management. If weight gain is inadequate, caloric intake is increased. Two-hour postprandial plasma glucose is measured at each office or clinic visit, with an acceptable upper limit of 120 mg/dl. If this limit is exceeded, the patient is hospitalized and, only if the prescribed diet does not maintain the plasma glucose within the acceptable range, insulin therapy is employed. The patient is then managed in the same way as any other insulin-dependent diabetic woman. Hospitalization is also employed for the gestational diabetic patient who develops preeclampsia, pyelonephritis, or hydramnios. The woman with uncomplicated gestational diabetes is managed on an ambulatory basis until she reaches her due date, awaiting the onset of labor. If labor does not ensue by 40 wk of gestation, and if a safe induction of labor cannot then be undertaken, she is admitted to the hospital for fetal surveillance with daily 24-h urinary estriols and electronic fetal monitoring until labor begins or until induction can be undertaken. During the years 1974 through 1978, there were 183 pregnancies at MacDonald House known to be complicated by gestational diabetes. Adequate blood glucose control was achieved by dietary means alone in 156 while 27 required insulin therapy. Thus, 15% of the total group required insulin therapy during the pregnancy to maintain normal plasma glucose levels. Total daily insulin doses ranged from 10 to 228 U, with only six patients requiring fewer than 25 U. As in our earlier report, to evaluate the effects of intervention in these 183 pregnancies, the outcomes were compared with the outcomes of prior pregnancies for the same women. There were 124 parous women in the group, with a total of 288 prior pregnancies attaining a stage of viability (Table 1). The most striking feature was the history of 28 perinatal deaths among these prior pregnancies, a 9.7% perinatal mortality rate. These losses consisted of 18 stillbirths and 10 neonatal deaths. It is also of note that an analysis of the prior pregnancies relative to the maternal age at each delivery fails to reveal any significant difference in the occurrence rate of perinatal losses for those women under 25 yr of age as compared with women aged 25 yr or older (Table 2). Macrosomia was also very common in these prior pregnancies (Table 3). Infants weighing 4000 g or more at birth comprised 19% of the ofjspring, while large-for-gestational-age (LGA) infants, i.e., above the 90th percentile on the Colorado growth curves, constituted 30% of the babies. As with perinatal mortality, the incidence of macrosomia in the prior pregnancies did not differ significantly relative to maternal age at the time of delivery (Table 2), although there appears to have been a trend toward more large babies among women aged 25 yr and over. During the 5-yr study period, the now detected gestational diabetic patients sustained two perinatal losses, one of which was a neonatal death in an infant with a chromosomal anomaly. This constitutes an uncorrected perinatal mortality rate of 1.1%, at least as good as the nondiabetic population and a
What problem does this paper attempt to address?